Your request to link to rcsb for BDBM18957

• 8E59: human l-type voltage-gated calcium channel cav1.3 in the presence of amiodarone at 3.1 angstrom resolution (10.1016/J.CELL.2022.10.024 )
• 8E5B: human l-type voltage-gated calcium channel cav1.3 in the presence of amiodarone and sofosbuvir at 3.3 angstrom resolution (10.1016/J.CELL.2022.10.024 )
• 8E56: rabbit l-type voltage-gated calcium channel cav1.1 in the presence of amiodarone at 2.8 angstrom resolution (10.1016/J.CELL.2022.10.024 )
• 8E57: rabbit l-type voltage-gated calcium channel cav1.1 in the presence of amiodarone and 100 microm mni-1 at 2.8 angstrom resolution (10.1016/J.CELL.2022.10.024 )
• 8E58: rabbit l-type voltage-gated calcium channel cav1.1 in the presence of amiodarone and 1 mm mni-1 at 3.0 angstrom resolution (10.1016/J.CELL.2022.10.024 )
• 5H4D: crystal structure of hsirt3 in complex with a specific agonist amiodarone hydrochloride
• 4O8Z: crystal structure of human sirt3 in complex with compound (2- butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl) methanone